EUVIMEDEUVIMED entdecken
Crossref

Macrolides and Immunomodulation

Eleni Karakike iD, Michael S Niederman

Seminars in Respiratory and Critical Care Medicine · 06.11.2026

DOI: 10.1055/a-2984-4704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, online erschienen am 06.11.2026. Verfasst von Eleni Karakike und 1 weiteren Autor:innen. Beteiligte Einrichtung: National and Kapodistrian University of Athens School of Health Sciences, Department of Critical Care, School of Nursing, Attica, Greece, Athens. Die Arbeit nennt 122 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrolides are widely used antibiotics, but their clinical benefits in the setting of infection and sepsis span beyond their antimicrobial spectrum. They possess immunomodulatory properties, characterized, across preclinical models, by effects on macrophage M1/M2 polarization, autophagy, neutrophil extracellular trap formation, cytokine release, and bacterial virulence factors. In hospitalized community-acquired pneumonia (CAP), macrolide and β-lactam combination therapy confers survival benefit, as supported by observational studies and meta-analyses, and reinforced by a recent randomized trial. In non-CAP sepsis, three randomized trials using adjunctive clarithromycin demonstrated earlier resolution of infection, prevention of secondary sepsis episodes, and a signal of improved survival among the most severely ill patients. With a low risk of serious adverse events, clarithromycin showed a cost-effective profile, compared with placebo. Mechanistic data, derived largely from biomarker analyses of these trials, point to a reversal of sepsis-induced immunoparalysis, including restored antigen presentation, monocyte reprogramming, and upregulation of cholesterol biosynthesis pathways. It is hypothesized that, depending on the timeline of infection and on host response, macrolides have a role as an immune “regulator” rather than purely anti-inflammatory properties.

Autor:innen und Institutionen

  • National and Kapodistrian University of Athens School of Health Sciences, Department of Critical Care, School of Nursing, Attica, Greece, Athens.
  • Weill Cornell Medicine, New York Presbyterian/Weill Cornell Medical Center, Division of Pulmonary and Critical Care Medicine, New York, United States, New York.

ORCID-Profile: Eleni Karakike

Zitieren

APA

Karakike, E., & Niederman, M. S. (2026). Macrolides and Immunomodulation. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/a-2984-4704

Vancouver

Karakike E, Niederman MS. Macrolides and Immunomodulation. Seminars in Respiratory and Critical Care Medicine. 2026. doi:10.1055/a-2984-4704

BibTeX
@article{Karakike2026,
  author = {Karakike, Eleni and Niederman, Michael S},
  title = {Macrolides and Immunomodulation},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  doi = {10.1055/a-2984-4704}
}
Kostenlos starten →